List of brands containing bezafibrate
This page contains list of brands of authorized pharmaceutical specialties of the active principle bezafibrate in the countries listed below:
[ Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Korea] [ Mexico] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]
Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.
The active ingredient bezafibrate belongs to a group of drugs called fibrates,which are a type of lipid-lowering drugs, ie that decrease blood fats.
This medicine is indicated in disorders of lipid metabolism, for lowering high cholesterol and other fats (triglycerides) in the blood when dietary and lifestyle measures are not sufficient.
Medizzine recommends that you consult your doctor if you are unsure why you have been prescribed bezafibrate.
Other ingredients of available commercial presentations:
Each tablet contains, besides the active ingredient (200 or 400 mg bezafibrate), lactose, polyvinylpyrrolidone, sodium lauryl sulfate, hydroxypropyl methylcellulose, colloidal silicon dioxide, magnesium stearate, Eudragit NE3OD, polyethylene glycol, talc, titanium dioxide, polysorbate 80, sodium citrate and purified water.
Warning
The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.
Do not use bezafibrate
If you are allergic (hypersensitive) to bezafibrate, to other fibrates or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.
Allergy symptoms may include:
- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).
Also, you should not take this medicine:
- If you are pregnant or breastfeeding.
- If you have a chronic or severe kidney disease.
- If you have any liver disease or abnormalities in the gallbladder with or without stones (cholestasis).
- If you are being treated with monoamine oxidase inhibitor drugs (MAOIs), medications for depression.
Take special care with bezafibrate
Before starting treatment with this medication, tell your doctor if:
- You are taking oral contraceptives with estrogen in its composition.
- You are taking medicines to lower cholesterol called statins or ion exchange resins.
- You are taking coumarin anticoagulants (acenocoumarol, warfarin).
- You suffer from muscle weakness or have a mild kidney disease.
If you are receiving a prolonged treatment with bezafibrate it is possible that your doctor will make frequent blood tests.
It is very important to follow the diet and other measures that your doctor has told.
If you experience any symptom indicating gallbladder stones as a severe abdominal pain, stop treatment and consult your doctor.
Your doctor will order blood tests to check the response to medication, more frequently if you are receiving a prolonged treatment.
Remember that your doctor has prescribed this medicine only for you. Never give it to someone else.
In the case of doubt, consult your doctor.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Especially:
Especially:
It is important that you tell your doctor if you take any of the following drugs:
- Bezafibrate potentiates the action of coumarin anticoagulants, therefore, your doctor will decrease the dose of anticoagulant at the beginning of treatment with this medicine and frequently monitor the blood clotting.
- Bezafibrate also enhances the action of drugs for diabetes (drugs to lower blood sugar). If you are taking these drugs, your doctor may decrease the dose of the antidiabetic.
- If you have undergone a transplant and are taking medicines to prevent rejection, your doctor may recommend that you discontinue therapy with bezafibrate.
- If you are taking any medication with ion exchange resins (cholestyramine) to reduce blood cholesterol levels, you should wait 2 hours at least between its administration and bezafibrate.
- Nor you should take this medicine if you are taking monoamine oxidase inhibitor drugs (MAOIs), a type of medication for depression.
Use with food and beverages
The retard formulation should be taken preferably after dinner. The standard formulation should be taken preferably after meals.
Special physiological situations
Pregnancy and lactation
Always consult your doctor or pharmacist before taking any medicine during pregnancy or lactation.
Bezafibrate is contraindicated during pregnancy and lactation.
Use in children:
Children should not take this medicine unless directed by the doctor, who will prescribe the most appropriate dose.
Driving and using machines
Have not been detected any effect on the patient's ability to drive or operate machinery.
Consult your doctor or pharmacist before taking any medicine.
Follow carefully instructions of use of bezafibrate provided by your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given in this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.
Remember to take your medicine. Do not stop treatment prematurely.
The dose of the retard formulation (400 mg) is 1 tablet a day. The usual dose of the standard formulation (200 mg) is 3 tablets a day.
The tablets should be swallowed without chewing, preferably after dinner. Take the tablets with a sufficient amount of liquid (a glass of water).
If you think that the effect of the medicine is too strong or too weak, consult your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, bezafibrate can cause side effects, although not everybody gets them.
The frequency of side effects is classified into:
Very common: affect 1 out of 1-10 patients
Common: affect 1 out of 10-100 patients
Uncommon: affect 1 out of 100-1.000 patients
Rare: affect 1 out of 1.000-10.000 patients
Very Rare: affect less than 1 in 10,000 patients
Incidence not known: Can not be established the true incidence from the available data
Although uncommon, the following side effects may appear:
Gastrointestinal disorders such as loss of appetite, bloating or nausea , which disappear generally without interrupting the treatment after 1 or 2 weeks.
Disorders of the liver or gallbladder and increased transaminases (tests that indicate liver function), biliary congestion, and appearance of gallstones (gallstones). If you experience any symptom indicator stones in the gallbladder as severe abdominal pain, stop treatment and consult your doctor.
Disorders of the skin and subcutaneous tissue: allergic reactions such as itching or urticaria and, in isolated cases, allergy to sunlight and generalized allergy. Rarely, hair loss.
Disturbances of blood and urine tests
Muscular disorders: muscular weakness, pain and muscle cramps. In the event of acute muscle pain without known cause, discontinue the medication.
Disorders of the central nervous system that can manifest themselves as strong headaches, and vertigo.
Reproductive system disorders: In isolated cases, erectile dysfunction
Respiratory disorders:fatigue (breathlessness)
This listing does not include all adverse reactions related to the use of bezafibrate, both well established as those that are under consideration or confirmation. In case you feel worse, consult with the doctor who has prescribed the drug IMMEDIATELY.
If you notice any side effects not listed in this website or in the leaflet accompanying the container, ask your doctor or pharmacist.
If any of the side effects gets serious, tell your doctor or pharmacist.
This page contains list of brands of authorized pharmaceutical specialties of the active principle bezafibrate in the countries listed below:
[ Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Korea] [ Mexico] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]
Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.
Warning:
With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.
Australia: ▲
BEZAFIBRATE ALPHAPHARM 200 mg, tablets
BEZAFIBRATE ALPHAPHARM 400 mg, modified release tablets
Brazil: ▲
BEZAFIBRATO EMS 200 mg, tablets
BEZAFIBRATO LEGRAND 200 mg, tablets
BEZAFIBRATO GERMED 200 mg, tablets
CEDUR 200 mg, tablets
CEDUR 400 mg, tablets
Canada: ▲
BEZALIP SR 400 mg, extended release tablets
PMS-BEZAFIBRATE 200 mg, tablets
France: ▲
BEFIZAL 200 mg, tablets
BEFIZAL L.P. 400 mg, extended release tablets
Germany: ▲
BEFIBRAT 200 mg, dragees
BEFIBRAT 400 mg, extended release tablets
BEZADOC 400 mg, extended release tablets
BEZAFIBRAT ABZ 400 mg, extended release tablets
BEZAFIBRAT AL 200 mg, tablets
BEZAFIBRAT AL 400 mg, extended release tablets
BEZAFIBRAT DURA 400 mg, extended release tablets
BEZAFIBRAT HEUMANN 400 mg, extended release tablets
BEZAFIBRAT HEXAL 400 mg, extended release tablets
BEZAFIBRAT SANDOZ 400 mg, extended release tablets
BEZAFIBRAT STADA 200 mg, tablets
BEZAFIBRAT STADA 400 mg, extended release tablets
BEZAFIBRAT-1 A PHARMA 400 mg, extended release tablets
BEZAFIBRAT-CT 200 mg, tablets
BEZAFIBRAT-CT 400 mg, extended release tablets
BEZAFIBRAT-RATIOPHARM 200 mg, tablets
BEZAFIBRAT-RATIOPHARM 400 mg, extended release tablets
BEZAGAMMA 200 mg, tablets
BEZAGAMMA 400 mg, extended release tablets
CEDUR 200 mg, tablets
CEDUR RETARD 400 mg, extended release tablets
India: ▲
BEZA-XL 400 mg, extended release tablets
BEZALIP 200 mg, tablets
BEZALIP 400 mg, tablets
BIZALIP 200 mg, tablets
BIZALIP 400 mg, tablets
BIZALIP-SR 400 mg, extended release tablets
Italy: ▲
BEZALIP 400 mg, extended release tablets
BEZAFIBRATO EG 400 mg, extended release tablets
HADIEL RETARD 400 mg, extended release tablets
Japan: ▲
BEZATOL SR 100 mg, extended release tablets
BEZATOL SR 200 mg, extended release tablets
BEZAFIBRATE JMA 200 mg, extended release tablets
BEFARLART SR 200 mg, extended release tablets
BERIATOL SR 200 mg, extended release tablets
VESTURIT-L 100 mg, extended release tablets
VESTURIT-L 200 mg, extended release tablets
BEZAFIBRATE TANABE SR 200 mg, extended release tablets
BEZALEX SR 100 mg, extended release tablets
BEZALEX SR 200 mg, extended release tablets
BEZALIP 100 mg, tablets
BEZALIP 200 mg, tablets
BESASTAR SR 100 mg, extended release tablets
BESASTAR SR 200 mg, extended release tablets
BEZATATE SR 100 mg, extended release tablets
BEZATATE SR 200 mg, extended release tablets
MIDENAL SR 100 mg, extended release tablets
MIDENAL SR 200 mg, extended release tablets
BERIATOL SR 200 mg, extended release tablets
Korea: ▲
BEJASTEROL 200 mg, tablets
BEZALIP 200 mg, tablets
BEZALIP RETARD 400 mg, extended release tablets
DEMIA 200 mg, tablets
Mexico: ▲
BEFITEC 200 mg, 30 tablets
BEZAFIBRATO KENER 200 mg, 30 tablets
BEZAFIBRATO BIORESEARCH 200 mg, 30 tablets
BEZAFISA 200 mg, 30 tablets
BEZALEX 200 mg, 30 tablets
BIFAREN 200 mg, 30 tablets
BIONOLIP 200 mg, 30 tablets
COLSER 200 mg, 30 tablets
FAZEBIT 200 mg, 30 tablets
LESBEST 200 mg, 30-50-100 tablets
LIPOCIN 200 mg, 30 tablets
NEPTALIP 200 mg, 30 tablets
REDALIP 200 mg, 30 tablets
SAFITAL 200 mg, 30 tablets
SAPRAME 200 mg, 30 tablets
ZAF-200 200 mg, 30 tablets
BEXALCOR SR 400 mg, 10 extended release tablets
COLSER RETARD L 400 mg, 10 extended release tablets
NIVETRIL 400 mg, 10-100 extended release tablets
Spain: ▲
DIFATEROL RETARD 400 mg, extended release capsules
EULITOP 200 mg, 30-60 tablets
EULITOP RETARD mg, 30 extended release tablets
Turkey: ▲
n/a
United Kingdom: ▲
BEZAFIBRATE AAH PHARMA 200 mg, tablets
BEZAFIBRATE ACTAVIS 200 mg, tablets
BEZAFIBRATE ALLIANCE HEALTHCARE 200 mg, tablets
BEZAFIBRATE ALLIANCE HEALTHCARE 400 mg, extended release tablets
BEZAFIBRATE GENERICS 200 mg, tablets
BEZALIP 200 mg, tablets
BEZALIP MONO 400 mg, modified-release tablets
FIBRAZATE XL 400 mg, modified-release tablets
U.S.A. and Puerto Rico: ▲
N/A
Page updated: October 23, 2010.
WARNING ABOUT THE CONTENTS
This page provides information to clarify some basic questions about this active principle. It is not exhaustive and, therefore, does not expose all of the available information and does not replace the information that can provide your doctor.
Like most drugs, this medication has risks and benefits. Your doctor has evaluated before prescribing, both ends. Any additional questions regarding this or any other medications, you should consult with your doctor.